Latest Commercialization News

Page 230 of 382
Audeara Ltd has reported a landmark FY25 with record cash receipts of $4.9 million, driven by strong domestic sales and expanding global technology partnerships. The company’s strategic R&D and inventory build set the stage for further growth in FY26.
Ada Torres
Ada Torres
24 July 2025
Fortescue Metals Group delivered record iron ore shipments in FY25 alongside a rare cost decline, while recalibrating its green energy ambitions and maintaining a strong financial position.
Maxwell Dee
Maxwell Dee
24 July 2025
PEXA’s UK arm has secured a formal commitment from NatWest to implement its digital platform for remortgage and sale & purchase transactions, marking a pivotal step in PEXA’s UK expansion.
Sophie Babbage
Sophie Babbage
24 July 2025
Calix Limited has secured a $44.9 million grant from ARENA to build a pioneering Green Iron Demonstration Plant using its ZESTY technology, aiming to produce 30,000 tonnes of low-emission iron annually and advance Australia’s green steel ambitions.
Victor Sage
Victor Sage
24 July 2025
Adisyn Ltd has made significant strides in developing low-temperature graphene semiconductor interconnects, commissioning a new Atomic Layer Deposition system and securing a major managed IT services contract, while maintaining a strong cash position.
Sophie Babbage
Sophie Babbage
24 July 2025
Lynas Rare Earths has achieved record quarterly production of key rare earth elements and reported a strong 38% increase in sales revenue, while advancing its Mt Weld expansion and signing strategic MOUs in Malaysia.
Maxwell Dee
Maxwell Dee
24 July 2025
Hiremii Limited reported a 4.4% revenue increase in Q4 FY25 alongside positive operating cash flow, while accelerating commercialisation of its proprietary AI recruitment platform and expanding through a key acquisition.
Sophie Babbage
Sophie Babbage
24 July 2025
Tungsten Mining NL (ASX – TGN) highlights its position as a key supplier of ethically sourced tungsten outside China, leveraging one of the world’s largest resource bases amid tightening global supply and rising prices.
Maxwell Dee
Maxwell Dee
24 July 2025
Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.
Ada Torres
Ada Torres
23 July 2025
Patrys Limited has launched a fully underwritten entitlement offer to raise approximately $1.77 million, aiming to accelerate development and commercial activities around its deoxymabs program.
Ada Torres
Ada Torres
23 July 2025
Mindax Limited has secured an option to acquire Norton Goldfields’ 35% stake in the Mt Forrest magnetite project, potentially gaining full ownership of a major iron ore asset in Western Australia’s Mid-West region.
Maxwell Dee
Maxwell Dee
23 July 2025
Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.
Ada Torres
Ada Torres
23 July 2025